ACRUX LIMITED (ACR)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for ACR during the last 90 days, indicating Moderate trading activity

Latest ACR Signals
29/05/2026	BUY
19/05/2026	SELL
02/04/2026	SELL
ACR Share Price
Current Price	$0.012
52 Week High	$0.021
52 Week Low:	$0.009
Trading at (% of 52 Week High)	57.14%

Business Overview

Acrux Limited (ASX: ACR) is an Australian specialty pharmaceutical company that develops and commercializes transdermal drug delivery systems. The company focuses on products for hormone replacement therapy and other prescription treatments. Acrux operates globally, partnering with other pharmaceutical companies to market its products.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for ACRUX LIMITED at a low price point suggests potential upside; however, the stock's low price and likely volatility reduce confidence. Limited liquidity and market capitalization may increase risk, warranting cautious consideration.

Latest  ACRUX LIMITED(ACR)   News